RobertAlanVigerskyMD
Endocrinology • Bethesda, MDDiabetes, Lipid Metabolism
Professor, Medicine, Uniformed Services Hebert SOM
Dr. Vigersky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Wisconsin Ave
# 509
Bethesda, MD 20889Phone+1 301-295-5165Fax+1 301-295-5170
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1972
Boston University School of MedicineClass of 1970
Certifications & Licensure
DC State Medical License 1978 - 2027
MD State Medical License 1976 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Continuous Glucose Monitoring in Patients With Type 2 Diabetes Start of enrollment: 2007 Sep 01
- Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes Start of enrollment: 2006 May 01
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAn Automated Insulin Delivery System with Automatic Meal Bolus Based on a Hand-Gesturing Algorithm.Anirban Roy, Benyamin Grosman, Andrea Benedetti, Bahman Engheta, Diana Miller
Diabetes Technology & Therapeutics. 2024-09-01 - 3 citationsAdvanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Mo...Tim van den Heuvel, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Roseline Ré
Journal of Diabetes Science and Technology. 2024-09-01 - 6 citationsEarly Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.James R Thrasher, Arcelia Arrieta, Fang Niu, Katherine R Cameron, Toni L Cordero
Diabetes Technology & Therapeutics. 2024-03-01
Press Mentions
FDA Rules Medtronic’s Insulin Pump Issues a Class I Recall Due to Safety RisksOctober 4th, 2024- Increasing Access to Diabetes Technology for Children with Type 1 DiabetesMay 12th, 2023
- New High-Tech Tools to Help Control DiabetesApril 27th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
